AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
logo

CLSD(Delisted)

Clearside Biomedical·NASDAQ
--
--(--)
4.71 / 10
Neutral

Analysts remain neutral (100% Neutral rating) with 33.3% historical win rate. Fund flow analysis shows 57%+ inflow ratios across all investor sizes, indicating positive capital allocation despite bankruptcy-related price collapse (-89.27% recently).

FundamentalSentiment(4.71)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

0%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-11-18
InstitutionNeedham
Times predicted6
Historical Win Rate33.3%